Ethics approval and consent to participate
The study protocol was approved by the Certified Review Board of Fukushima Medical University (no. F2023001). The study is now conducted in accordance with the Declaration of Helsinki and the Clinical Trial Act in Japan. After the patients are initially screened for eligibility based on their prior medical records, they will receive adequate explanations about the trial plan before they provide a written informed consent.